In the BC group, the positive rate of lymph node metastasis, ER, PR and Her2 expression were 38.0%, 72.2%, 69.5% and 86.6%, respectively. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.